User profiles for Rajesh Pandey

Rajesh Pandey

- Verified email at mmumullana.org - Cited by 4714

Rajesh Pandey

- Verified email at igib.in - Cited by 2869

[HTML][HTML] SARS-CoV-2 B. 1.617. 2 Delta variant replication and immune evasion

…, R Datir, DA Collier, A Albecka, S Singh, R Pandey… - Nature, 2021 - nature.com
The B.1.617.2 (Delta) variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
was first identified in the state of Maharashtra in late 2020 and spread throughout India, …

Genomic characterization and epidemiology of an emerging SARS-CoV-2 variant in Delhi, India

…, N Soni, L Thukral, S Flaxman, S Bhatt, R Pandey… - Science, 2021 - science.org
Delhi, the national capital of India, experienced multiple severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) outbreaks in 2020 and reached population seropositivity of >50…

Poly (dl-lactide-co-glycolide) nanoparticle-based inhalable sustained drug delivery system for experimental tuberculosis

R Pandey, A Sharma, A Zahoor… - Journal of …, 2003 - academic.oup.com
Objectives: To improve the bioavailability of antitubercular drugs (ATDs) as well as to
assess the feasibility of administering ATDs via the respiratory route, this study reports the …

Solid lipid particle-based inhalable sustained drug delivery system against experimental tuberculosis

R Pandey, GK Khuller - Tuberculosis, 2005 - Elsevier
The present study was planned to evaluate the chemotherapeutic potential of nebulized
solid lipid particles (SLPs) incorporating rifampicin, isoniazid and pyrazinamide against …

Role of mixed metal oxides in catalysis science—versatile applications in organic synthesis

MB Gawande, RK Pandey, RV Jayaram - Catalysis Science & …, 2012 - pubs.rsc.org
A variety of mixed metal oxides (MMOs), containing alkali, alkaline, rare earth and noble
metals, and their applications are presented. In this mini review, we summarize versatile …

[PDF][PDF] Alginate nanoparticles as antituberculosis drug carriers: formulation development, pharmacokinetics and therapeutic potential

Z Ahmad, R Pandey, S Sharma… - Indian journal of chest …, 2006 - academia.edu
Background. Reduction in the dosing frequency of antituberculosis drugs (ATDs) by
applying drug delivery technology has the potential to improve the patient compliance in …

Oral solid lipid nanoparticle-based antitubercular chemotherapy

R Pandey, S Sharma, GK Khuller - Tuberculosis, 2005 - Elsevier
The present study was planned to evaluate the chemotherapeutic potential of oral solid lipid
nanoparticles (SLNs) incorporating rifampicin, isoniazid and pyrazinamide against …

Effectiveness of ChAdOx1 nCoV-19 vaccine against SARS-CoV-2 infection during the delta (B. 1.617. 2) variant surge in India: a test-negative, case-control study and …

…, BK Desiraju, P Kshetrapal, R Pandey… - The Lancet Infectious …, 2022 - thelancet.com
Background SARS-CoV-2 variants of concern (VOCs) have threatened COVID-19 vaccine
effectiveness. We aimed to assess the effectiveness of the ChAdOx1 nCoV-19 vaccine, …

Nanoparticle encapsulated antitubercular drugs as a potential oral drug delivery system against murine tuberculosis

R Pandey, A Zahoor, S Sharma, GK Khuller - Tuberculosis, 2003 - Elsevier
Patient non-compliance is the major drawback associated with the long-duration
chemotherapy of tuberculosis (TB); hence, reduction in dosing frequency forms an important …

Nano-encapsulation of azole antifungals: potential applications to improve oral drug delivery

R Pandey, Z Ahmad, S Sharma, GK Khuller - International journal of …, 2005 - Elsevier
The present study was designed to improve the oral bioavailability of two clinically important
antifungal drugs—clotrimazole and econazole. Each drug was encapsulated in …